Heartburn & Stomach Medication Recalls
Recalls of acid reducers and stomach drugs - the class behind the ranitidine (Zantac) nitrosamine recalls.
209 recalls in this category, newest first.
Class II · Moderate risk Ongoing Mar 26, 2026
Reason Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Class II · Moderate risk Ongoing Dec 30, 2025
Reason Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and…
Class II · Moderate risk Ongoing Nov 17, 2025
Reason Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and…
Class I · High risk Ongoing Nov 6, 2025
Reason Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Class II · Moderate risk Ongoing Jun 30, 2025
Reason Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.
Class II · Moderate risk Ongoing May 13, 2025
Reason Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during…
Class II · Moderate risk Ongoing May 13, 2025
Reason Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during…
Class III · Low risk Ongoing Nov 14, 2024
Reason Labeling: Not Elsewhere Classified - Wrong NDC number
Class II · Moderate risk Completed Feb 2, 2024
Reason Subpotent Drug: Out of specification for assay
Class II · Moderate risk Ongoing Dec 29, 2023
Reason Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.
Class II · Moderate risk Completed Nov 14, 2023
Reason Failed pH Specifications
Class III · Low risk Terminated Oct 23, 2023
Reason Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18…
Class II · Moderate risk Terminated Sep 5, 2023
Reason Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Class II · Moderate risk Terminated May 1, 2023
Reason Labeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton…
Class II · Moderate risk Completed Apr 7, 2023
Reason CGMP Deviations; The impacted product and lot number was inadvertently placed into saleable inventory, which does not comply with approved procedures.
Class II · Moderate risk Ongoing Mar 14, 2023
Reason CGMP Deviations: Discoloration
Class II · Moderate risk Terminated Dec 27, 2022
Reason Lack of sterility assurance
Class II · Moderate risk Terminated Dec 27, 2022
Reason Lack of sterility assurance
Class II · Moderate risk Terminated Jul 25, 2022
Reason Discoloration
Class II · Moderate risk Ongoing Jun 23, 2022
Reason CGMP Deviations: product held outside appropriate storage temperature conditions.
Class II · Moderate risk Ongoing Jun 23, 2022
Reason CGMP Deviations: product held outside appropriate storage temperature conditions.
Class III · Low risk Terminated Jun 21, 2022
Reason Superpotent Drug: Out of specification for assay at the 12-month timepoint.
Class III · Low risk Terminated Jun 21, 2022
Reason Superpotent Drug: Out of specification for assay at the 12-month timepoint.
Class II · Moderate risk Completed May 9, 2022
Reason Lack of assurance of sterility.
Class II · Moderate risk Terminated Apr 13, 2022
Reason cGMP deviations: Temperature abuse